Stay updated on Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial
Sign up to get notified when there's something new on the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page.

Latest updates to the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page
- Check2 days agoChange DetectedThe study record now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates an updated revision of the study record on the page.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision label updated to v3.6.2. This represents a minor maintenance update to the page's underlying software and does not alter the study content or layout.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays a recruitment-status note ('No longer looking for participants') and adds new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). It also adjusts the Intervention/Treatment header formatting and updates the revision tag to v3.6.0.SummaryDifference0.6%

- Check31 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a maintenance update to the page without altering core content. No user-visible changes are expected.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new revision of the ClinicalTrials.gov page. This denotes an update to the page’s metadata or backend, not the substantive study details.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page’s footer/site revision number was updated from v3.5.2 to v3.5.3, indicating a minor technical/version update rather than a change to the clinical study information.SummaryDifference0.1%

Stay in the know with updates to Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Dose-Finding Study of SYNT001 in Pemphigus Clinical Trial page.